Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

252 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-10-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We are interested in studying whether and how medical problems other than primary cancer before hematopoietic cell transplantation would impact the profiles of quality of life and toxicities post-transplantation for patients with blood cancers. We want to see if by assessing comorbidities (such as diabetes) early on, we can identify those patients who will have more toxicities or limitations in their quality of life after transplant. The generated information could set the stage for future intervention studies aiming to improve quality of life for patients with blood cancers after transplantation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant

NCT05722210

Hematopoietic Stem Cell Transplant

NOT_YET_RECRUITING

Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant

NCT00004994

Bone Marrow Transplantation

COMPLETED

Hematopoetic Stem Cell Transplant and Physical Function

NCT03103308

Cancer Walking

COMPLETED NA

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

NCT01890486

Acute Myelogenous Leukemia Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia +7 more

RECRUITING

Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation

NCT02598752

Acute Myeloid Leukemia Myelodysplastic Syndrome Hematological Malignancy +3 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematologic Malignancies Other Diagnoses, Comorbidities, and Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Allogeneic HCT candidates who are \>18 years of age
* Able to speak and read English
* Able to provide informed consent
* Access to a telephone for study-related communications
* Diagnosed with a hematological malignant disease
* Willing to complete survey packets at 5 time-points, spanning two years

Exclusion Criteria

* HCT candidates who are 18 years or younger at the time of study enrollment
* HCT candidates who cannot read, write, or speak English
* Patients with diagnoses of non-malignant diseases, or solid tumors are primary disease

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No